R. Reis

Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome

J. Squire, T. Vidotto, LP Chaves, 2022, bioRxiv.

Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome

J. Squire, T. Vidotto, LP Chaves, 2023, bioRxiv.

Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome

J. Squire, T. Vidotto, LP Chaves, 2023, bioRxiv.

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

A. Giglio, M. Wroclawski, M. Tobias-Machado, 2010, Prostate Cancer and Prostatic Diseases.